GenomOncology
Cleveland, US · Founded 2012 · Ohio LLC · 51 employees on LinkedIn · 1 known investors
GenomOncology builds precision oncology software, including its Precision Oncology Platform (POP) and a Pathology Workbench, along with content and curation data products for clinical genomics. It serves clinicians and researchers in cancer care through healthcare IT and bioinformatics tools.
Founders & leadership
JY
Justin YeakleyChief Information Security Officer & SVP, Product Development
LP
Len PagonNamed on SEC filing
JS
Jeff SmithNamed on SEC filing
JS
Jonathan SeatonNamed on SEC filing
BL
Brian LadenNamed on SEC filing
LZ
Lee ZapisNamed on SEC filing
BW
Brad WertzNamed on SEC filing
Investors · 1
Reported raises · per SEC filings
Form D private placements$4.6M disclosed across 2 rounds · 2019–2020
▶$3.2MraisedApr 2020 · 10 investors · Other Health CareRule 506(b)
▶$3.2MraisedApr 2020 · 10 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Jonathan SeatonDirector
- Brian LadenDirector
- Len PagonDirector
- Jeff SmithExecutive Officer
- Brad WertzExecutive Officer, Director
- Lee ZapisDirector
- Offering amount
- $4.2M
- Amount sold
- $3.2M
- First sale
- Apr 2020
- Incorporated
- Limited Liability Company, Ohio
- Federal exemptions
- 06b
▶$1.4MraisedNov 2019 · 13 investors · Other Health CareRule 506(b)
▶$1.4MraisedNov 2019 · 13 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Len PagonDirector
- Jeff SmithExecutive Officer
- Jonathan SeatonDirector
- Brian LadenDirector
- Lee ZapisDirector
- Brad WertzExecutive Officer, Director
- Offering amount
- $1.8M
- Amount sold
- $1.4M
- First sale
- Nov 2019
- Incorporated
- Limited Liability Company, Ohio
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 2
by search overlap
IDbyDNA64 shared keywordsScalable, high throughput DNA sequencing platforms.
Labcorp33 shared keywordsLabcorp provides clinical laboratory testing, diagnostics, and lab data services for patients, healthcare providers, and biopharma companies, including genetic health panels, oncology testing, and self-ordered lab tests. It also offers AI-powered tools such as a results-explaining consumer app, a diagnostic assistant integrated into EHRs, and a laboratory data analytics platform to support drug development and clinical research.
Companies competing with GenomOncology for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does GenomOncology do?
- GenomOncology builds precision oncology software, including its Precision Oncology Platform (POP) and a Pathology Workbench, along with content and curation data products for clinical genomics. It serves clinicians and researchers in cancer care through healthcare IT and bioinformatics tools.
- Who are GenomOncology's investors?
- GenomOncology's investors include Relevance Ventures.
- How much funding has GenomOncology raised?
- GenomOncology has disclosed $4.6M raised across 2 rounds.
- Where is GenomOncology headquartered?
- GenomOncology is headquartered in Cleveland, US.